Clinical Trial Update: A Study to Assess THN391 in Subjects With Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 study of THN391 in Alzheimer's disease, early onset, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• THN391

Snippet

Sponsor: Therini Bio, Inc. | Conditions: Alzheimer Disease, Early Onset | Phase 1 | Status: RECRUITING